SOX9 and breast carcinoma: Sry-related high motility group box 9 (SOX9) plays active roles during tumorigenesis and progression in various types of human cancers and was reported to be upregulated in tamoxifen-resistant breast cancer and to drive breast cancer endocrine resistance [51, 52].